Exposure to a wide variety of carcinogens leads to the formation of DNA adducts. Measurement of DNA adduct content in cells provides direct evidence for exposure and damage. Analysis of these so-called molecular markers are becoming an accepted tool for assessing human health risk. Our long term objective is the correlation between the presence of DNA adducts and carcinogenesis in target tissues. We are investigating DNA adducts of aromatic amines, a class of compounds found in cigarette smoke and protein-containing foods. Epidemiological studies have established the carcinogenicity of certain aromatic amines such as 4- aminobiphenyl (ABP), 2-naphthylamine and 2-amino-3-methylimidazo[4,5- f]quinoline (IQ) in both humans and animals. These compounds can be converted to electrophilic intermediates containing nitrene and nitrenium ion functional groups. These species are known to attack predominantly the C8 position of guanine residues. Pancreatic, lung or colon cancerous tissues contain DNA adducts of one or more of these compounds as well as the enzymes capable of activating them. Improved methods for detection and characterization of DNA adducts are important toward our goal of establishing their direct relationship to cancer. Capillary separation methods (HPLC and capillary electrophoresis) coupled to electrospray ionization/tandem mass spectrometry will be used to analyze human lung and pancreatic tissues from smokers in order to assess the role of ABP in human carcinogenesis. Tissues from animal models exposed to aromatic amines will be used as surrogates in developing the methodology. Comparisons will be made to 32P- post- labeling, currently the most widely used method of adduct analyses. However, this methodology does not provide direct structural information or sequence preferences of the adduct. To address these important issues, CE-MS will be used to characterize oligonucleotide adducts in order to determine sequence recognition patterns of carcinogens. It is expected that this program will lead to the establishment of a rigorous mass spectrometric methodology for the study of DNA adducts and the use of biomarkers for risk assessment.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA069390-04
Application #
2848981
Study Section
Metallobiochemistry Study Section (BMT)
Program Officer
Poland, Alan P
Project Start
1996-05-18
Project End
2003-02-28
Budget Start
1999-05-01
Budget End
2000-02-29
Support Year
4
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Northeastern University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
039318308
City
Boston
State
MA
Country
United States
Zip Code
02115
Gathungu, Rose M; Kautz, Roger; Kristal, Bruce S et al. (2018) The integration of LC-MS and NMR for the analysis of low molecular weight trace analytes in complex matrices. Mass Spectrom Rev :
Flarakos, Caroline Ceailles; Weiskopf, Andrew; Robinson, Matthew et al. (2017) Metabolism of selective 20-epi-vitamin D3 analogs in rat osteosarcoma UMR-106 cells: Isolation and identification of four novel C-1 fatty acid esters of 1?,25-dihydroxy-16-ene-20-epi-vitamin D3. Steroids 119:18-30
Schneider, Bradley B; Nazarov, Erkinjon G; Londry, Frank et al. (2016) Differential mobility spectrometry/mass spectrometry history, theory, design optimization, simulations, and applications. Mass Spectrom Rev 35:687-737
Klaene, Joshua J; Flarakos, Caroline; Glick, James et al. (2016) Tracking matrix effects in the analysis of DNA adducts of polycyclic aromatic hydrocarbons. J Chromatogr A 1439:112-123
Bhattacharya, Arup; Klaene, Joshua J; Li, Yun et al. (2015) The inverse relationship between bladder and liver in 4-aminobiphenyl-induced DNA damage. Oncotarget 6:836-45
Sharma, Vaneet K; Xiong, Wennan; Glick, James et al. (2014) Determination of site selectivity of different carcinogens for preferential mutational hot spots in oligonucleotide fragments by ion-pair reversed-phase nano liquid chromatography tandem mass spectrometry. Eur J Mass Spectrom (Chichester) 20:63-72
Gathungu, Rose M; Bird, Susan S; Sheldon, Diane P et al. (2014) Identification of metabolites from liquid chromatography-coulometric array detection profiling: gas chromatography-mass spectrometry and refractionation provide essential information orthogonal to LC-MS/microNMR. Anal Biochem 454:23-32
Kafle, Amol; Coy, Stephen L; Wong, Bryan M et al. (2014) Understanding gas phase modifier interactions in rapid analysis by differential mobility-tandem mass spectrometry. J Am Soc Mass Spectrom 25:1098-113
Rhieu, Steve Y; Annalora, Andrew J; Wang, Guochun et al. (2013) Metabolic stability of 3-epi-1?,25-dihydroxyvitamin D3 over 1 ? 25-dihydroxyvitamin D3: metabolism and molecular docking studies using rat CYP24A1. J Cell Biochem 114:2293-305
Gathungu, Rose M; Flarakos, Caroline C; Reddy, G Satyanarayana et al. (2013) The role of mass spectrometry in the analysis of vitamin D compounds. Mass Spectrom Rev 32:72-86

Showing the most recent 10 out of 55 publications